Target intelligence / Profile preview

Genomic DNA locus specified by the ABE8e single-guide RNA (ABE8e target site)

Target
ABE8e target site
Molecular classification
Genomic DNA, Nucleic acid
01

Overview

The genomic DNA locus specified by the ABE8e single-guide RNA (sgRNA) refers to the precise chromosomal sequence targeted for nucleotide modification by the Adenine Base Editor 8e (ABE8e) system (Richter et al., 2020, Nature Biotechnology). ABE8e is a CRISPR-derived tool consisting of a catalytically impaired Cas9 nickase (nCas9) fused to an evolved TadA-8e deoxyadenosine deaminase (Gaudelli et al., 2017, Nature). The sgRNA directs the complex to a complementary 20-nucleotide DNA sequence, where the deaminase converts a target adenine (A) to inosine (I) within a specific activity window (Richter et al., 2020, Nature Biotechnology). Because inosine is recognized as guanine (G) by DNA polymerases, this process results in a permanent A•T to G•C base pair transition without the need for double-strand breaks (Newby et al., 2021, Nature). This target is not a single biological entity but rather a class of genomic sites that can be modified to treat genetic diseases or study gene function (Kim et al., 2019, Nature Biotechnology). Therapeutic application requires careful design to avoid bystander editing of adjacent adenines and off-target effects at unintended genomic locations (Kim et al., 2019, Nature Biotechnology).

Other names
CRISPR-Cas9 target siteBase editing locusProtospacer sequenceABE8e-targeted sequenceAdenine base editor target
02

Mechanism of action

Adenine deamination leading to A•T to G•C base pair transition

03

Biological functions

Genetic information storageGene expression regulation
04

Disease associations

Genetic disorderHereditary diseaseCancer
05

Safety considerations

Off-target editingBystander editing (editing of non-target adenines in the window)Immunogenicity of Cas9 or deaminase proteinsChromosomal translocationsUnintended RNA editing
06

Interacting drugs

ABE8e (Adenine Base Editor 8e)

1 more in the full profile.

07

Biomarkers

A-to-G editing efficiencyDNA sequencing (Sanger or NGS)Indel frequencyInosine-to-G conversion rate

Beyond the preview

Go deeper on Genomic DNA locus specified by the ABE8e single-guide RNA (ABE8e target site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genomic DNA locus specified by the ABE8e single-guide RNA (ABE8e target site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call